In esophageal cancer, it inhibits tumor growth by regulating apoptosis and the NF-κB signaling pathway, increasing radiosensitivity, increasing the expression of cleaved caspase 3 and Bax, and decreasing Bcl-2 and NF-κB levels in vitro [29]. Here, BCL2 is linked to esophageal cancer.